Matthew Weston Stock Analyst Profile - UBS Research Coverage - Stocknear

Matthew Weston

Stock Analyst at UBS

(4.05)
# 1961
Out of 5,474 analysts
4
Total ratings
Success rate
Average return
Main Sectors:
3 Stocks
Name Action PT Current % Upside Ratings Updated
NVO Novo Nordisk
Downgrades: Neutral
n/a
n/a n/a 1 Aug 5, 2025
NVS Novartis
Downgrades: Neutral
n/a
n/a n/a 1 Feb 13, 2025
AZN AstraZeneca
Upgrades: Buy
n/a
n/a n/a 2 Feb 13, 2025